Anne-Sophie Bouin1, Michael Wierer2. 1. European Directorate for the Quality of Medicines & Healthcare (EDQM), Council of Europe, 7 Allée Kastner, Cs 30026, F-67081 Strasbourg, France. Electronic address: anne-sophie.bouin@edqm.eu. 2. European Directorate for the Quality of Medicines & Healthcare (EDQM), Council of Europe, 7 Allée Kastner, Cs 30026, F-67081 Strasbourg, France.
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: The European Pharmacopoeia (Ph. Eur.) provides a legal and scientific reference for the quality control of medicines. It is legally binding in the 38 signatory parties of the Convention on the elaboration of a European Pharmacopoeia (37 member states and the European Union). MATERIALS AND METHODS: The requirements for a specific herbal drug are prescribed in the corresponding individual monograph and the relevant general monographs. Criteria for pesticides and heavy metals for example are defined in the general monograph on Herbal drugs. The Ph. Eur. also provides general methods including methods for determination of aflatoxins B1 and ochratoxin A. Screening methods for aristolochic acids are applied for herbal drugs that may be subject to adulteration or substitution with plant material containing aristolochic acids. CONCLUSION: The Ph. Eur. collaborate in many areas with the European Medicines Agency (EMA) to ensure close collaboration as regards the respective work programmes and approach.
ETHNOPHARMACOLOGICAL RELEVANCE: The European Pharmacopoeia (Ph. Eur.) provides a legal and scientific reference for the quality control of medicines. It is legally binding in the 38 signatory parties of the Convention on the elaboration of a European Pharmacopoeia (37 member states and the European Union). MATERIALS AND METHODS: The requirements for a specific herbal drug are prescribed in the corresponding individual monograph and the relevant general monographs. Criteria for pesticides and heavy metals for example are defined in the general monograph on Herbal drugs. The Ph. Eur. also provides general methods including methods for determination of aflatoxins B1 and ochratoxin A. Screening methods for aristolochic acids are applied for herbal drugs that may be subject to adulteration or substitution with plant material containing aristolochic acids. CONCLUSION: The Ph. Eur. collaborate in many areas with the European Medicines Agency (EMA) to ensure close collaboration as regards the respective work programmes and approach.
Authors: Heinrich Magometschnigg; Katja Pinker; Thomas Helbich; Anita Brandstetter; Margaretha Rudas; Thomas Nakuz; Pascal Baltzer; Wolfgang Wadsak; Marcus Hacker; Michael Weber; Peter Dubsky; Martin Filipits Journal: Mol Imaging Biol Date: 2019-10 Impact factor: 3.488
Authors: Mahmoud M A Elsayed; Moustafa O Aboelez; Mohamed S Mohamed; Reda A Mahmoud; Ahmed A El-Shenawy; Essam A Mahmoud; Ahmed A Al-Karmalawy; Eman Y Santali; Sameer Alshehri; Mahmoud Elkot Mostafa Elsadek; Mohamed A El Hamd; Abd El Hakim Ramadan Journal: Pharmaceutics Date: 2022-08-04 Impact factor: 6.525